Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences
Senior Manager
Telephone: 412-578-9193 or 412-624-3212

Patients and medical professionals may call 1-800-533-UPMC (8762) for more information.

Pitt Scientists Receive $3.6 Million to Test Vaccine Against Deadliest Strain of Avian Flu ​

PITTSBURGH, August 25, 2008 – Scientists at the University of Pittsburgh Center for Vaccine Research have been awarded $3.6 million from the National Institute of Allergy and Infectious Diseases to conduct animal studies of vaccines designed to protect against the most common and deadliest strain of avian flu, H5N1. Recent outbreaks of H5N1 have prompted health officials to warn of its continued threat to global health and potential to trigger an avian flu pandemic.

“Worldwide avian flu control efforts have been mostly successful, but like seasonal influenza, avian flu changes year to year, creating new subtypes and strains that could easily and quickly spread among humans,” said Ted M. Ross, Ph.D., principal investigator of the grant and assistant professor, Center for Vaccine Research, University of Pittsburgh.

Unlike other avian flu vaccines, which are partially developed from live viruses, the vaccines Dr. Ross and colleagues will test in non-human primates are based on a virus-like particle, or VLP, that is recognized by the immune system as a real virus but lacks genetic information to reproduce, making it a potentially safer alternative for a human vaccine. Given the evolving nature of H5N1, the vaccines have been engineered to encode genes for many influenza viral proteins to offer enhanced protection against possible new strains of the virus.

“VLPs may be advantageous over other vaccine strategies because they are easy to develop, produce and manufacture,” said Dr. Ross. “Using recombinant technologies, within ten weeks, we could generate a vaccine most effective towards the current circulating strain of virus, making it a cost-effective counter-measure to the threat of an avian influenza pandemic.” 

Co-investigators at the University of Pittsburgh include Simon M. Barratt-Boyes, Ph.D., Department of Infectious Diseases and Microbiology; Gerard J. Nau, M.D., Ph.D. and Jodi K. Craigo, Ph.D., Department of Microbiology and Molecular Genetics; Elodie Ghedin, Ph.D., Department of Medicine; and Clayton A. Wiley, M.D., Department of Pathology.

The Center for Vaccine Research (CVR) at the University of Pittsburgh houses both the Regional Biocontainment Laboratory and the Vaccine Research Laboratory. Researchers at the CVR, directed by Donald S. Burke, M.D., dean of the University of Pittsburgh Graduate School of Public Health and UPMC Jonas Salk Professor of Global Health, develop new methods and strategies to prevent and treat infectious diseases, potentially improving and protecting global health.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com